Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: Correlation with blood levels in patients with metastatic breast cancer-Reference-Cited by-同舟云学术

Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: Correlation with blood levels in patients with metastatic breast cancer

Published:1981-10 Issue:4 Volume:2 Page:381-390
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Fabian Carol,Tilzer Lowell,Sternson Larry

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference24 articles.

1. Oestrogen receptors and antagonism of steroid hormone action

2. EFFECT OF SOME TRIPHENYLETHYLENES ON OESTRADIOL BINDING IN VITRO TO MACROMOLECULES FROM UTERUS AND ANTERIOR PITUITARY

3. Estrogen receptor · anti-estrogen complex: Atypical binding by uterine nuclei and effects on uterine growth

4. Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat

5. A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITY

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous quantification of 4-hydroxytamoxifen and hesperidin in liposomal formulations: Development and validation of a RP-HPLC method;Heliyon;2024-02

2. The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer;Biomedicine & Pharmacotherapy;2024-01

3. Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor‐Targeted Drug Delivery;Advanced Therapeutics;2023-07-19

4. Non-systemic Approaches for Ductal Carcinoma In Situ: Exploring the Potential of Ultra-flexible Combisomes as a Novel Drug Delivery Strategy—a Review;AAPS PharmSciTech;2023-05-12

5. Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy;RSC Medicinal Chemistry;2023